Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.
Marchetti
Piero
P
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. marchant@immr.med.unipi.it
Lupi
Roberto
R
Del Guerra
Silvia
S
Bugliani
Marco
M
D'Aleo
Valentina
V
Occhipinti
Margherita
M
Boggi
Ugo
U
Marselli
Lorella
L
Masini
Matilde
M
D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D018450:Disease Progression; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology; D018149:Glucose Intolerance / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D008137:Longitudinal Studies; D008687:Metformin / Q000494:pharmacology
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin